comparemela.com

Latest Breaking News On - Ivy brain tumor center - Page 1 : comparemela.com

Black Diamond Therapeutics Presents Promising BDTX-1535

Results from Phase 1 dose escalation trial of BDTX-1535 in GBM patients demonstrated a favorable safety and tolerability profile, and encouraging.

Cambridge
Cambridgeshire
United-kingdom
Black-diamond
Arizona
United-states
American
Patrick-wen
Nader-sanai
Mario-corso
International-conference-on-molecular
Nasdaq

Black Diamond Therapeutics Presents Promising BDTX-1535 Clinical Data in Patients with ...

Results from Phase 1 dose escalation trial of BDTX-1535 in GBM patients demonstrated a favorable safety and tolerability profile, and encouraging anti-tumor activity and duration of treatment

Black-diamond
Arizona
United-states
Cambridge
Cambridgeshire
United-kingdom
American
Patrick-wen
Nader-sanai
Mario-corso
American-society-of-clinical-oncology
Exchange-commission

vimarsana © 2020. All Rights Reserved.